Effects of combined low-density lipoprotein apheresis and aggressive statin therapy on coronary calcified plaque as measured by computed tomography.
Hoffmann
Udo
U
Department of Diagnostic Radiology, University and General Hospital of Vienna, Vienna, Austria. uhoffmann@partners.org
Derfler
Kurt
K
Haas
Martin
M
Stadler
Alfred
A
Brady
Thomas Joseph
TJ
Kostner
Karam
K
D000284:Administration, Oral; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D001781:Blood Component Removal / Q000379:methods*; D002114:Calcinosis / Q000097:blood / Q000000981:diagnostic imaging* / Q000235:genetics / Q000628:therapy*; D008078:Cholesterol, LDL / Q000097:blood*; D003131:Combined Modality Therapy; D003324:Coronary Artery Disease / Q000097:blood / Q000000981:diagnostic imaging* / Q000235:genetics / Q000628:therapy*; D016903:Drug Monitoring; D005260:Female; D005500:Follow-Up Studies; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006579:Heterozygote; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000150:complications* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000627:therapeutic use*; D012720:Severity of Illness Index; D019821:Simvastatin / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin; D019821:Simvastatin